No pain, no gain! GL!

Great post. Agree on all points.

Agree...a lot of people got scared with the A/S increase. Once the dust settles and future news about the progress of MANF develops, we will be fine.

Monies will be paid to Amarantus under the note in four separate tranches of $150,000 over a 6 week period, subject to certain milestones.

Dominion is not blindly giving out the loan. $AMBS still has to hit certain milestones, so they still have to deliver!

http://www.investopedia.com/ask/answers/121.asp#axzz2C9PS34fQ

Don't stop believing! LOL

michaeland1

Thursday, November 08, 2012 3:17:27 PM
Re: None
Post # of 10205
The filing today suggests major events happening within 30 days:

http://biz.yahoo.com/e/121108/ambs8-k.html

Throw in comments from rubinfeld (from Amgen) and comments from Michael j fox foundation about how promising MANF is and it's astounding how cheap this is at a $7 million market cap.

Why the sudden change of heart? Did you sell and trying to buy back lower?


michaeland1

Saturday, November 10, 2012 11:26:46 PM
Re: None
Post # of 10203
John Commissiong is pretty legit. He has been published numerous times. Here is an older publication from 2006:

http://onlinelibrary.wiley.com/doi/10.1111/j.1471-4159.1990.tb04575.x/abstract

Another on from 1993:
http://www.springerlink.com/content/j543855l55g77287/


Another from 1994:
http://www.jneurosci.org/content/14/8/4769.full.pdf

You'll be rich!!! Just saying! :)

Thanks CJ for all the DD you have done. Some might feel you post too much, but you provide good info. Best of luck at the doctors. See you back here on Friday!

Nice catch. Thanks for posting.

If you are long, why worry about a measly 14 MILL added to the float. At least we know an actual company is 'buying' the shares at a known price. Imagine if they just dumped this onto the market (like what most P&D/scam company would do).

If everything they are working on pans out, we'll run even if we max out the A/S. 250mill shares is nothing compared to most micro-cap BIO companies.

GO $AMBS

Iron Ridge has done all their DD before handing over $500,000 in exchange for shares of AMBS @ .051. They know it is going to go much much higher.

Thanks Carter for updating the iBox share structure!

Really helps with potential investors and bashers always bringing up the "D" word.

Days like these are good. Strong support!

GO $AMBS

Not a broken record....nice to hear, just in case we forget the gem we have here.

If the right PRs keep coming...we won't have long to wait.

GO $AMBS

Sounds like everyone is getting ready to bail at .10.

Anyone waiting for .5-$1+ or I'm being greedy.

I have had a GTC sell for at least 1 month. None has sold so far.

'mental issues' - that sums it up. :)

Best to ignore posters that aren't able to present valid reasons why a stock would go down. Especially, when their posting history is always negative on all stocks.

Go $AMBS!

This is getting old quick! Let this run dammit!

Did you cover today? If this is going down, I hope it goes down again tomorrow.

Hell yeah!

Almost 300 board followers!

It's ok...we want buyers in the $1 - $2 range. :)

Would appreciate a PM of the second email if its not too much trouble. Thanks.

When all else fails...bring out the 'D' word or P&D, never fails.

Good and logical post.

I still see this going as high as .08-.12 next week. The updated PR is way overblown. More PRs to come next week.

Come again?? I was replying to ' Oger '

Yes, they need money to fund MANF!!! hahaah

Yup...it all depends on which side you're on and how the information is dissected.

This is how I interpreted the corrected release.

Here is the quote of contention:

Original PR: "Upon completion of the data analysis correlate of the positive behavioural animal data for MANF previously reported with histology data confirming re-innervation of the striatum due to MANF delivery to the substantia nigra,..."

Corrected: "MJFF reserves any view on the histology results until the final data are available"

Obviously AMBS has completed the data analysis and they feel positive about the results. Until MNFF receives the final results, they cannot confirm whether it's good or not.

Original PR: "...the Michael J. Fox Foundation will consider funding additional studies to advance MANF as a disease-modifying treatment for Parkinson's disease."

Corrected: "In addition, MJFF is not considering additional funding to Amarantus at this time."

I don't know the details of the original grant, so no way I can tell which is correct. From MNFF's point of view, again without knowing the results, perhaps they don't want to give the impression that they 'will' provide additional funding. Moreover, even in the original PR, it only states that MJFF 'will consider' funding, not necessarily they will.

"MJFF continues to invest in promising neurotrophic factor approaches, and will apply takeaways from this study to future initiatives. The Foundation still believes that MANF is a potentially promising trophic factor.

Based on the last statement, if MJFF agrees with AMBS's report and potential treatment. I don't see why they won't grant additional funding for next phase testing.

That's my opinion on the corrected PR.

All MJFF is saying is they are reserving judgement on the results until they get to analyze it. Doesn't mean it's good or bad.

SUNNYVALE, Calif., Nov. 9, 2012 /PRNewswire/ -- Amarantus BioSciences, Inc. (OTCQB: AMBS) is issuing corrections to a press release dated November 7 regarding data from a study into MANF, funded by The Michael J. Fox Foundation (MJFF). 

To clarify remarks in the original release, MJFF does not agree with Amarantus' statements that, to-date, reported behavioural pre-clinical data were positive, and that histology data confirm re-innervation of the striatum due to MANF delivery. MJFF reserves any view on the histology results until the final data are available.  In addition, MJFF is not considering additional funding to Amarantus at this time. Amarantus has announced the final data will be available in December.

MJFF continues to invest in promising neurotrophic factor approaches, and will apply takeaways from this study to future initiatives.  The Foundation still believes that MANF is a potentially promising trophic factor. 

Hope it continues!

The dip to the 3s was a blessing in disguise as you say the weak hands were shaken out. We have stronger shareholders.

Second this.

Traders will say anything to get in and out.

**********************

ALL-IN888 Member Profile ALL-IN888

Thursday, November 08, 2012 11:24:45 AM
Re: mOe tHe mAn post# 5981
Post # of 6905

Monday or Tuesday next week! Load up now! I've accumulated a ton down here! 1M

With Dr. Rubinfeld and others on the Advisory Board, they have the people in place to take this company to the next levels.